EvokAI Creative Labs Inc
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$870K
-0.38
Evokai Creative Labs, Inc. engages in the development of transformational and innovative technologies for the modern healthcare sector. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-05-09. The company is engaged in the development of transformational technologies for the modern healthcare sector. The company deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. The company tailors its artificial intelligence (AI) algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, to medical professionals, patients, healthy individuals, aiming at preventing any kind of disease and, beyond, protecting the aging genome. The firm has a single operating segment, which is involved in the research and development and commercialization of artificial intelligence-based products and services for the MedTech sector.
Evokai Creative Labs, Inc. engages in the development of transformational and innovative technologies for the modern healthcare sector. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-05-09. The company is engaged in the development of transformational technologies for the modern healthcare sector. The company deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. The company tailors its artificial intelligence (AI) algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, to medical professionals, patients, healthy individuals, aiming at preventing any kind of disease and, beyond, protecting the aging genome. The firm has a single operating segment, which is involved in the research and development and commercialization of artificial intelligence-based products and services for the MedTech sector.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.